CELEGHINI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 7.645
EU - Europa 3.044
AS - Asia 2.939
SA - Sud America 237
Continente sconosciuto - Info sul continente non disponibili 188
AF - Africa 53
OC - Oceania 6
Totale 14.112
Nazione #
US - Stati Uniti d'America 7.560
SG - Singapore 1.079
PL - Polonia 805
CN - Cina 758
UA - Ucraina 442
SE - Svezia 414
IT - Italia 360
HK - Hong Kong 287
VN - Vietnam 226
FI - Finlandia 196
BR - Brasile 172
KR - Corea 156
TR - Turchia 153
GB - Regno Unito 146
FR - Francia 142
BD - Bangladesh 124
DE - Germania 113
RU - Federazione Russa 108
IE - Irlanda 89
BG - Bulgaria 72
CH - Svizzera 67
IN - India 47
CA - Canada 45
BE - Belgio 21
MX - Messico 21
NL - Olanda 20
MA - Marocco 19
IQ - Iraq 18
AR - Argentina 17
GR - Grecia 14
CL - Cile 13
JP - Giappone 13
ID - Indonesia 12
CO - Colombia 10
ES - Italia 9
PH - Filippine 8
ZA - Sudafrica 8
AT - Austria 7
PE - Perù 6
PY - Paraguay 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
EC - Ecuador 5
KE - Kenya 5
TH - Thailandia 5
UZ - Uzbekistan 5
AM - Armenia 4
AU - Australia 4
EU - Europa 4
MY - Malesia 4
SN - Senegal 4
UY - Uruguay 4
CZ - Repubblica Ceca 3
EG - Egitto 3
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
JO - Giordania 3
KG - Kirghizistan 3
LB - Libano 3
NP - Nepal 3
PK - Pakistan 3
RO - Romania 3
SV - El Salvador 3
VE - Venezuela 3
AL - Albania 2
BH - Bahrain 2
BY - Bielorussia 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PA - Panama 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
HR - Croazia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
MR - Mauritania 1
NG - Nigeria 1
PT - Portogallo 1
QA - Qatar 1
SR - Suriname 1
Totale 13.930
Città #
Fairfield 838
Woodbridge 737
Warsaw 732
Ashburn 696
Singapore 609
Ann Arbor 535
Houston 514
Chandler 415
Jacksonville 399
Wilmington 352
Seattle 335
San Jose 317
Hong Kong 284
Cambridge 273
Hefei 202
Seoul 153
Princeton 144
Izmir 139
Beijing 137
Boardman 137
Dallas 121
Columbus 115
Council Bluffs 111
Chicago 99
Dublin 72
Sofia 72
Los Angeles 68
Lauterbourg 67
Zgierz 66
Helsinki 65
Bern 62
Trieste 62
Ho Chi Minh City 59
Santa Clara 57
Buffalo 55
Hanoi 54
Moscow 54
Milan 48
San Diego 47
Dearborn 43
New York 43
The Dalles 43
Frankfurt am Main 41
Menlo Park 31
Des Moines 22
Nanjing 21
São Paulo 21
London 20
Guangzhou 18
Phoenix 18
Shanghai 18
Falls Church 16
Verona 16
Brussels 15
Casablanca 15
Ferrara 14
Orem 14
Rome 13
Atlanta 12
Denver 12
Jinan 12
Miano 12
Brooklyn 11
Hangzhou 11
Tokyo 11
Corinth 10
Da Nang 10
Dong Ket 10
Redwood City 10
Auburn Hills 9
Düsseldorf 9
Kunming 9
Montreal 9
Norwalk 9
Washington 9
Mexico City 8
Nanchang 8
Naples 8
Redondo Beach 8
Vancouver 8
Amsterdam 7
Baghdad 7
Haiphong 7
Sacile 7
San Francisco 7
Shenzhen 7
Tianjin 7
Toronto 7
Xi'an 7
Chennai 6
Johannesburg 6
Miami 6
Portsmouth 6
Santiago 6
Zhengzhou 6
Boston 5
Hebei 5
Kocaeli 5
Mumbai 5
North Bergen 5
Totale 10.083
Nome #
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 461
Neuronal Dysfunction Associated with Cholesterol Deregulation. 442
Repositioning Of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice 394
In vitro evaluation of the anti-inflammatory properties of Echinacea and Ginger in normal and pathological pregnancy 361
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 344
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 322
Pre-eclampsia affects procalcitonin production in placental tissue 320
An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies. 290
Complement component C1q as potential diagnostic but not predictive marker of preeclampsia 262
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. 258
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 256
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL). 235
Design, Synthesis, and Biological Characterization of Novel Mitochondria Targeted Dichloroacetate-Loaded Compounds with Antileukemic Activity 233
Effect of recombinant TRAIL in a murine co-culture system of osteoclastogenesis 232
TNF-related apoptosis inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. 231
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 231
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. 217
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells. 214
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 213
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 211
Potential role of circulating microRNAs as early markers of preeclampsia 210
Anti-leukemic activity of Dasatinib in both p53(wild-type) and p53(mutated) B malignant cells. 208
PMA-induced megakaryocytic differentiation of HEL cells is accompanied by striking modifications of protein kinase C catalytic activity and isoform composition at the nuclear level. 205
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. 202
HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand. 201
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. 201
Total extract of Beta vulgaris var. cicla seeds versus its purified phenolic components: antioxidant activities and antiproliferative effects against colon cancer cells. 199
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-Rays absorptiometry 197
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members. 196
Potential pathogenetic implications of cyclooxygenase-2 overexpression in Bchronic lymphoid leukemia cells 192
Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo. 189
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 186
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 186
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 184
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells. 181
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 176
Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies. 175
Recent advances in the therapeutic perspectives of Nutlin-3 173
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 171
Differential effects of stromal derived factor-1a (SDF-1a) on early and late stages of human megakaryocytic development. 168
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate. 166
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL). 165
Selective modulation of specific protein kinase C (PKC) isoforms in primary human megakaryocytic vs. erythroid cells. 164
Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells 163
Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. 162
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro. 161
All-Trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients. 160
In vivo and in vitro modulatory effect of human immunodeficiency virus type-1 (HIV-1) Tat protein on protein kinase C activity. 159
Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 159
Thrombopoietin enhances the aIIbb3-dependent adhesion of megakaryocytic cells to fibrinogen or fibronectin through PI 3 kinase. 157
Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival. 153
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis. 149
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway. 148
Impaired survival of bone marrow GPIIb/IIIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia. 147
HIV-1 Tat protein suppresses the nerve growth factor (NGF)-mediated differentiation of PC12 rat pheochromocytoma cell line. 147
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia. 147
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. 147
In vitro senescence and apoptotic cell death of human megakaryocytes. 146
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 144
Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells. 140
Subcellular localization of the regulatory HIV-1 Tat protein produced endogenously by or added exogenously to PC12 rat pheochromocytoma and human Jurkat T lymphoid cells. 138
MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies 137
The induction of megakaryocyte differentiation is accompanied by selective Ser133 phosphorylation of the transcription factor CREB in both HEL cell line and primary CD34+ cells. 134
Levels of circulating TNF‑related apoptosis‑inducing ligand in celiac disease 134
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitus 131
NF-κB pathways in hematological malignancies 129
The engagement of CD4 surface antigen in the HEL haemopoietic cell line up-regulates the transforming growth factor-b1 (TGF-b1) promoter activity. 123
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 123
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib. 122
In situ polymerase chain reaction tecnique revealed by flow cytometry as a tool for gene detection. 112
Pleiotropic effects of immobilized versus soluble recombinant HIV-1 Tat protein on CD3-mediated activation, induction of apoptosis, and HIV-1 long terminal repeat transactivation in purified CD4+ T lymphocytes. 109
Morphological features of apoptosis in hematopoietic cells belonging to the T-lymphoid and myeloid lineages. 109
Totale 14.112
Categoria #
all - tutte 40.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.123


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022704 0 0 32 67 31 80 44 23 97 91 74 165
2022/20231.166 94 125 84 170 118 231 1 108 172 6 44 13
2023/2024627 93 48 37 55 48 52 120 101 5 5 30 33
2024/20251.272 20 29 65 183 132 169 42 76 171 121 93 171
2025/20263.404 252 198 288 229 258 351 566 124 384 423 189 142
2026/2027457 147 192 118 0 0 0 0 0 0 0 0 0
Totale 14.112